Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer

Abstract Objective Dose-dense chemotherapy has shown a better prognosis than standard interval chemotherapy in adjuvant settings for high-risk breast cancer. This study aimed to evaluate the efficacy and safety of dose-dense nanoparticle albumin-bound paclitaxel followed by dose-dense epirubicin and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Japanese journal of clinical oncology 2023-12, Vol.53 (12), p.1119-1124
Hauptverfasser:	Matsumoto, Akiko, Jinno, Hiromitsu, Naruse, Saki, Isono, Yuka, Maeda, Yuka, Sato, Ayana, Yamada, Miki, Ikeda, Tatsuhiko, Sasajima, Yuko
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumin-Bound Paclitaxel - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Breast Neoplasms - drug therapy Breast Neoplasms - pathology Breast Neoplasms - surgery Cyclophosphamide - adverse effects Epirubicin - adverse effects Female Humans Mastectomy Neoadjuvant Therapy Paclitaxel - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!